Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Here's Why Quest Diagnostics Stock Should Be in Your Portfolio
01:07am, Monday, 31'st Oct 2022
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022.
COVID-19 testing volume has 'come down,' Quest Diagnostics CEO says
01:39pm, Monday, 24'th Oct 2022
Quest Diagnostics CEO Steve Rusckowski joins Yahoo Finance Live to discuss the state of the coronavirus pandemic, testing demand, manufacturing capacity, and the outlook for the industry.
Quest Diagnostics (DGX) Just Overtook the 200-Day Moving Average
01:50pm, Friday, 21'st Oct 2022 Zacks Investment Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Quest Diagnostics (DGX) Just Overtook the 200-Day Moving Average
11:17am, Friday, 21'st Oct 2022
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Why Quest Diagnostics Stock Jumped Today
10:41pm, Thursday, 20'th Oct 2022 The Motley Fool
Growth in the lab testing titan's core business is accelerating.
Why Quest Diagnostics Stock Jumped Today
06:41pm, Thursday, 20'th Oct 2022
Growth in the lab testing titan's core business is accelerating.
Quest Diagnostics (DGX) Beats on Q3 Earnings, Ups Revenue View
05:03pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Banking on consistent improvement in the company's Base business, Quest Diagnostics (DGX) raised its full-year 2022 revenue guidance.
Quest Diagnostics stock pops as it raises full-year guidance
05:02pm, Thursday, 20'th Oct 2022
Yahoo Finance Live anchors Seana Smith, Josh Schafer and Dave Briggs looks at Quest Diagnostics shares following its boosted guidance.
Quest Diagnostics Incorporated (DGX) CEO Steve Rusckowski on Q3 2022 Results - Earnings Call Transcript
03:40pm, Thursday, 20'th Oct 2022
Quest Diagnostics Incorporated (NYSE:DGX ) Q3 2022 Earnings Conference Call October 20, 2022 8:30 AM ET Company Participants Shawn Bevec - VP of IR Steve Rusckowski - Chairman, President & Chief Execu
Quest Diagnostics (DGX) Beats on Q3 Earnings, Ups Revenue View
02:18pm, Thursday, 20'th Oct 2022
Banking on consistent improvement in the company's Base business, Quest Diagnostics (DGX) raised its full-year 2022 revenue guidance.
Quest Diagnostics (DGX) Tops Q3 Earnings and Revenue Estimates
12:05pm, Thursday, 20'th Oct 2022 Zacks Investment Research
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 8.76% and 5.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics (DGX) Tops Q3 Earnings and Revenue Estimates
09:47am, Thursday, 20'th Oct 2022
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 8.76% and 5.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics earnings fall but beat expectations, even as COVID-19 testing revenue drops 55%
06:59am, Thursday, 20'th Oct 2022
Quest Diagnostics Inc. DGX, -2.25% reported Thursday third-quarter profit and revenue that fell from a year ago but beat expectations, as base business performance rebounding in the latter part of the
Dividend Champion, Contender, And Challenger Highlights: Week Of October 16
04:36am, Sunday, 16'th Oct 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the dividend stocks update for the week of October 16 here.
Quest Diagnostics (DGX) to Report Q3 Earnings: What's in Store?
04:23pm, Friday, 14'th Oct 2022 Zacks Investment Research
The non-COVID base business is expected to have gained from Quest Diagnostics' (DGX) efforts to expand value-based contracts with payers.
